Cargando…

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center

PURPOSE: Early clinical trials of recombinant human activated protein C (rhAPC) for severe sepsis excluded patients at high risk of bleeding. Recent literature suggests bleeding rates are higher in clinical practice and may be associated with worsened outcomes. Our objective was to evaluate baseline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anger, Kevin E, DeGrado, Jeremy R, Greenwood, Bonnie C, Cohen, Steven A, Szumita, Paul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678900/ https://www.ncbi.nlm.nih.gov/pubmed/23766652 http://dx.doi.org/10.2147/TCRM.S45412

Ejemplares similares

Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics
por: DeGrado, Jeremy R, et al.
Publicado: (2011)

Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center
por: Cook, Meghan E., et al.
Publicado: (2023)

Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center
por: Aldhaeefi, Mohammed, et al.
Publicado: (2022)

Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
por: Schuler, Brian R., et al.
Publicado: (2020)

Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
por: Kovacevic, Mary P., et al.
Publicado: (2021)

The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors
por: Corrado, Michael J., et al.
Publicado: (2020)

Evaluation of the impact of a prescribing guideline on the use of intraoperative dexmedetomidine at a tertiary academic medical center
por: Alhammad, Abdullah M., et al.
Publicado: (2017)

Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019
por: DeGrado, Jeremy R., et al.
Publicado: (2020)

2101. Impact of “Code Sepsis” on Antimicrobial Utilization at an Academic Medical Center
por: Kang, Minji, et al.
Publicado: (2019)

Updated estimates of sepsis hospitalizations at United States academic medical centers
por: Chan, Hei Kit, et al.
Publicado: (2022)

Pain prevalence in hospitalized patients at a tertiary academic medical center: Exploring severe persistent pain
por: Wu, Chieh-Liang, et al.
Publicado: (2020)

Severe sepsis: variation in resource and therapeutic modality use among academic centers
por: Yu, D Tony, et al.
Publicado: (2003)

[(18)F]Tetrafluoroborate ([(18)F]TFB) and its analogs for PET imaging of the sodium/iodide symporter
por: Jiang, Huailei, et al.
Publicado: (2018)

Prospective evaluation of inappropriate unable-to-assess CAM-ICU documentations of critically ill adult patients
por: Terry, Kimberly J., et al.
Publicado: (2015)

422. Brucellosis Regimens Comparison in a Saudi Tertiary Academic Medical Center
por: Alalawi, Mai, et al.
Publicado: (2018)

The spectrum of skin diseases seen in a Jamaican tertiary academic medical center
por: East-Innis, Althea D.C., et al.
Publicado: (2021)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
por: Lemke, Lauren K., et al.
Publicado: (2023)

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
por: Pandey, Mukesh K., et al.
Publicado: (2016)

Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
por: Pandey, Mukesh K., et al.
Publicado: (2021)

Characterization of Nocturnal Neuroactive Medication Use and Related Sleep Documentation in Critically Ill Adults
por: Hamidi, Arzo, et al.
Publicado: (2021)

Challenges of Implementing the 4Ms in Federally Qualified Health Centers and Private Academic Medical Centers
por: Olsen, Bonnie, et al.
Publicado: (2020)

Evaluation of interventional endoscopy unit efficiency metrics at a tertiary academic medical center
por: Yang, Dennis, et al.
Publicado: (2016)

Implementation of an Automated Electronic Medical Record “Antibiotic Timeout” Alert at a Tertiary, Academic Medical Center
por: James, Charles, et al.
Publicado: (2017)

A Real-Time All-Atom Structural Search Engine for Proteins
por: Gonzalez, Gabriel, et al.
Publicado: (2014)

Endocrinology practice patterns of hypothyroidism and osteoporosis management in a U.S. tertiary academic medical center
por: Shim, Jien, et al.
Publicado: (2019)

Effects of COVID-19 on Blood Culture Contamination at a Tertiary Care Academic Medical Center
por: Sacchetti, Brianna, et al.
Publicado: (2022)

Identification of the main contributors to blood culture contamination at a tertiary care academic medical center
por: Sacchetti, Brianna, et al.
Publicado: (2022)

THU604 Characterization Of Adrenal Masses In Young Adults At A Tertiary Academic Medical Center
por: Jacob, Sarah A, et al.
Publicado: (2023)

2235. Characterization of the Adult Sepsis Treatment Guideline Utilization Within the Emergency Department at an Academic Medical Center
por: Berg, Deanna M, et al.
Publicado: (2023)

Measuring the academic value of academic medical centers: describing a methodology for developing an evaluation model at one Academic Medical Center
por: Hod, Rafael, et al.
Publicado: (2019)

Assessment of pediatric residents burnout in a tertiary academic center
por: Yoo, Hyo H., et al.
Publicado: (2018)

Evaluation of Thyroidectomy Results Performed at a Tertiary Academic Center
por: Emre, Fatih Yunus, et al.
Publicado: (2023)

The Incidence of Urgent Tube Shunt Surgery for Diabetic Neovascular Glaucoma at a Tertiary Academic Medical Center
por: LaRocca, Megan Corinne, et al.
Publicado: (2023)

An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs
por: Mao, Lili, et al.
Publicado: (2013)

Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics
por: Watkins, Laura C., et al.
Publicado: (2020)

Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
por: Hu, Yanmei, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 related illness – A community academic medical center experience
por: Meleveedu, Kapil S, et al.
Publicado: (2020)

Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag
por: Rocchio, Megan A, et al.
Publicado: (2013)

Drotrecogin alfa in patients with severe sepsis: experience from a tertiary care center in North India
por: Chawla, R, et al.
Publicado: (2007)

Impact of Geographical Cohorting in the ICU: An Academic Tertiary Care Center Experience
por: Kapoor, Rajat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lldi3v0qkti2bkm4a0j6gu46fi